Literature DB >> 15177180

Quiescent murine cells lack global genomic repair but are proficient in transcription-coupled repair.

Jason H Bielas1, John A Heddle.   

Abstract

The majority of the cells in the body, including stem cells, exist in a quiescent state, so it is in quiescent cells where most DNA damage occurs. It has been uncertain whether or not this damage is repaired or fixed into mutations during quiescence or if proliferation is required for both. Prior to the development of transgenic mice, it was difficult to distinguish between these two possibilities, as cells had to proliferate to form colonies before mutations could be detected. Transgenes, however, can be shuttled out of quiescent mouse cells directly, and the level of DNA damage and mutation can be measured. Such measurements show that both mutation and repair are absent at a non-transcribed transgene in quiescent cells, although both are initiated when these cells are induced to proliferate. Conversely, the repair of transcriptionally active genes proceeds independently of proliferation in the same cells, as shown by the differential survival of wild-type and XPA-/- cells. We infer from these results that global genomic DNA repair (GGR) is not active during cellular quiescence but that transcription-coupled repair (TCR) is, suggesting that GGR is restricted to S, whereas TCR remains active throughout the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177180     DOI: 10.1016/j.dnarep.2004.02.010

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  9 in total

1.  Ronin influences the DNA damage response in pluripotent stem cells.

Authors:  Bryce A Seifert; Marion Dejosez; Thomas P Zwaka
Journal:  Stem Cell Res       Date:  2017-07-03       Impact factor: 2.020

2.  Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.

Authors:  Xiaobing Deng; Daina Z Ewton; Eileen Friedman
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

3.  Two- and three-dimensional models for risk assessment of radiation-enhanced colorectal tumorigenesis.

Authors:  Andres I Roig; Suzie K Hight; Jerry W Shay
Journal:  Radiat Res       Date:  2009-01       Impact factor: 2.841

Review 4.  The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.

Authors:  P J Brooks
Journal:  DNA Repair (Amst)       Date:  2008-05-20

5.  Mirk regulates the exit of colon cancer cells from quiescence.

Authors:  Kideok Jin; Daina Z Ewton; Sunju Park; Jing Hu; Eileen Friedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

6.  The dynamics of E1A in regulating networks and canonical pathways in quiescent cells.

Authors:  Jean-Eudes Dazard; Keman Zhang; Jingfeng Sha; Omar Yasin; Linda Cai; Chien Nguyen; Mrinal Ghosh; Jennifer Bongorno; Marian L Harter
Journal:  BMC Res Notes       Date:  2011-05-26

7.  A random mutation capture assay to detect genomic point mutations in mouse tissue.

Authors:  Jocelyn H Wright; Kristina L Modjeski; Jason H Bielas; Bradley D Preston; Nelson Fausto; Lawrence A Loeb; Jean S Campbell
Journal:  Nucleic Acids Res       Date:  2011-04-01       Impact factor: 16.971

8.  Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons.

Authors:  Mohamed Abdouh; Wassim Chatoo; Jida El Hajjar; Jocelyn David; José Ferreira; Gilbert Bernier
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer.

Authors:  Eileen Friedman
Journal:  Cancers (Basel)       Date:  2010-07-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.